ProPhase Labs appoints Jed Latkin as COO; CFO Robert Morse returns to Controller role

ProPhase Labs, Inc.

Jed Latkin named COO effective Jan 1, 2024; base salary $350,000, sign-on bonus $80,000.
Latkin receives inducement stock options for 500,000 shares at $6.00, vesting over 3 years (25% immediate).
Robert Morse ceases as CFO and resumes Controller role effective Jan 1, 2024, reporting to COO.
Press release highlights 2024 growth plans for Nebula Genomics, Pharmaloz Manufacturing, and BE-SMART test commercialization.
Latkin previously served as CEO of Navidea and has 28+ years in finance and biotech.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Robert A. Morse

Controller

PRPH · ProPhase Labs, Inc.

Effective: 2024-01-01
Filed: January 4, 2024, 6:59 PM ET

Robert A. Morse mutually agreed that Mr. Morse would cease to be Chief Financial Officer of the Company and resume his role as Controller of the Company, effective January 1, 2024,

Appointed

Jed A. Latkin

Chief Operating Officer

PRPH · ProPhase Labs, Inc.

Effective: 2024-01-01
Filed: January 4, 2024, 6:59 PM ET

Jed A. Latkin has been appointed to serve as Chief Operating Officer of the Company, effective on January 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert A. Morse changed role as Controller at ProPhase Labs, Inc..

Action: ceased as CFO and resumed as Controller
Role: Controller

Exact text from the filing

Robert A. Morse mutually agreed that Mr. Morse would cease to be Chief Financial Officer of the Company and resume his role as Controller of the Company, effective January 1, 2024,

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jed A. Latkin was appointed as Chief Operating Officer at ProPhase Labs, Inc..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

Jed A. Latkin has been appointed to serve as Chief Operating Officer of the Company, effective on January 1, 2024.

View on SEC.gov

ProPhase Labs, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-000578

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.